Following the genericization of blood thinner Plavix and hypertension treatment Avapro/Avalide in major markets across the globe, partners Bristol-Myers Squibb Company ( BMY ) and Sanofi (
Teleflex Incorporated ( TFX ), a global leader in medical devices used in critical care and surgery, recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)
Edwards Lifesciences ( EW ) reported disappointing third quarter 2012 results. The company expects to report $448 million in sales (representing year-over-year growth of 9% or 14% at